跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 195 条关于
“CD56”
全部
195
临床试验
103
药物
69
机构
0
资讯
23
去年
Compass Therapeutics' CTX-471 Shows Promise with NCAM Biomarker Correlation in Advanced Malignancies
去年
Compass Therapeutics Advances Pipeline with New Bispecific Antibody Candidate
2年前
Expert Highlights Critical Role of Early Diagnosis and Targeted Therapy in BPDCN Management
10个月前
AI-Assisted Immune Profiling Reveals Novel Lymphocyte Signatures in Soft Tissue Sarcoma
2年前
Nadunolimab Shows Promise in Patients with Cancer Progression After PD-1 Inhibitor Therapy
去年
Compass Therapeutics Reports Promising Clinical Data Across Bispecific Antibody Pipeline
去年
Two Decades of NK Cell Trials Show Promise for AML Treatment with 37% Complete Remission Rate
去年
Neoadjuvant Immunochemotherapy Shows Promising Results in Locally Advanced Oral Squamous Cell Carcinoma
2个月前
Mapping the Tumor Microenvironment: Immune Pathway Signatures Predict Immunotherapy Outcomes in Melanoma
上个月
Machine Learning Identifies HNRNPA2B1, RPE, and TAF15 as Potential Stress Granule-Related Biomarkers for Childhood Asthma
第 1 页,共 3 页
上一页
下一页